The data includes three cell lines MCF10A (normal), MDA-MB-231 (triple negative breast cancer), and HCC1937 (triple negative breast cancer with BRCA1 mutant) with either hydroxyurea treatment (TR) or untreated (UT) samples. The gene discussed is BRCA1; the disease is triple-negative breast carcinoma.